Cited by 392

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide

Puglielli, Luigi, Konopka, Genevieve, Pack-Chung, Eunju, Ingano, Laura A. MacKenzie, Berezovska, Oksana, Hyman, Bradley T., Chang, Ta Yuan, Tanzi, Rudolph E., Kovacs, Dora M.·2001·Nature Cell Biology

Abstract

The pathogenic event common to all forms of Alzheimer's disease is the abnormal accumulation of the amyloid beta-peptide (Abeta). Here we provide strong evidence that intracellular cholesterol compartmentation modulates the generation of Abeta. Using genetic, biochemical and metabolic approaches, we found that cholesteryl-ester levels are directly correlated with Abeta production. Acyl-coenzyme A:cholesterol acyltransferase (ACAT), the enzyme that catalyses the formation of cholesteryl esters, modulates the generation of Abeta through the tight control of the equilibrium between free cholesterol and cholesteryl esters. We also show that pharmacological inhibitors of ACAT, developed for the treatment of atherosclerosis, are potent modulators of Abeta generation, indicating their potential for use in the treatment of Alzheimer's disease.

Overview

Integrity signals

Registry

Crossref · 10.1038/ncb1001-905

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23–A31 (1999). · DOI · Paper page
  2. De Strooper, B. & Annaert, W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857–1870 (2000). · DOI
  3. Tanzi, R. E. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J. Clin. Invest. 104, 1175–1179 (1999). · DOI
  4. Jarvik, G. P. et al. Interaction of apolipoprotein E genotype, total cholesterol level, and sex in prediction of Alzheimer disease in a case-control study. Neurology 45, 1092–1096 (1995). · DOI
  5. Koudinov, A. R., Berezov, T. T. & Koudinova, N. V. Alzheimer's amyloid β and lipid metabolism: a missing link? FASEB J. 12, 1097–1099 (1998). · DOI
  6. Lee, S. J. et al. A detergent-insoluble membrane compartment contains Aβ in vivo. Nature Med. 4, 730–734 (1998). · DOI
  7. Refolo, L. M., Wittenberg, I. S., Friedrich V. L Jr. & Robakis, N. K. The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J. Neurosci. 11, 3888–3897 (1991). · DOI
  8. Parkin, E. T., Turner, A. J. & Hooper, N. M. Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem. J. 344, 23–30 (1999). · DOI
  9. Mizuno, T., Haass, C., Michikawa, M. & Yanagisawa, K. Cholesterol-dependent generation of a unique amyloid β-protein from apically missorted amyloid precursor protein in MDCK cells. Biochim. Biophys. Acta 1373, 119–130 (1998). · DOI
  10. Bodovitz, S. & Klein, W. L. L. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436–4440 (1996). · DOI · Paper page
  11. Simons, M. et al. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460–6464 (1998). · DOI
  12. Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H. & Austen, B. M. The role of cholesterol in the biosynthesis of β-amyloid. Neuroreport 10, 1699–1705 (1999). · DOI
  13. Howland, D. S. et al. Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholesterol. J. Biol. Chem. 273, 16576–16582 (1998). · DOI
  14. Refolo, L. M. et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321–331 (2000). · DOI · Paper page
  15. Chang, T. Y., Chang, C. C. & Cheng, D. Acyl-coenzyme A:cholesterol acyltransferase. Annu. Rev. Biochem. 66, 613–638 (1997). · DOI · Paper page
  16. Brown, M. S. & Goldstein, J. L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl Acad. Sci. USA 96, 11041–11048 (1999). · DOI · Paper page
  17. Brown, D. A. & London, E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell. Dev. Biol. 14, 111–136 (1998). · DOI
  18. Incardona, J. P. & Eaton, S. Cholesterol in signal transduction. Curr. Opin. Cell Biol. 12, 193–203 (2000). · DOI
  19. Blanchette-Mackie, E. J. Intracellular cholesterol trafficking: role of the NPC1 protein. Biochim. Biophys. Acta 1486, 171–183 (2000). · DOI
  20. Chang, T. Y. et al. Chinese hamster ovary cell mutants affecting cholesterol metabolism. Curr. Opin. Lipidol. 8, 65–71 (1997). · DOI
  21. Reinhart, M. P. Intracellular sterol trafficking. Experientia 46, 599–611 (1990). · DOI
  22. Ross, S. L. et al. Amyloid precursor protein processing in sterol regulatory element- binding protein site 2 protease-deficient Chinese hamster ovary cells. J. Biol. Chem. 273, 15309–15312 (1998). · DOI
  23. Tomita, T., Chang, T. Y., Kodama, T. & Iwatsubo, T. βAPP γ-secretase and SREBP site 2 protease are two different enzymes. Neuroreport 9, 911–913 (1998). · DOI
  24. Chang, C. C. et al. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 275, 28083–28092 (2000). · DOI
  25. Irie, T. et al. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. J. Pharmacobiodyn. 5, 741–744 (1982). · DOI
  26. Hansen, G. H., Niels-Christiansen, L. L., Thorsen, E., Immerdal, L. & Danielsen, E. M. Cholesterol depletion of enterocytes. Effect on the Golgi complex and apical membrane trafficking. J. Biol. Chem. 275, 5136–5142 (2000). · DOI
  27. Rogers, M. J. Statins: lower lipids and better bones? Nature Med. 6, 21–23 (2000). · DOI
  28. Wang, I. K., Lin-Shiau, S. Y. & Lin, J. K. Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells. Pharmacol. Toxicol. 86, 83–91 (2000). · DOI
  29. Simons, M. Molecular multitasking: statins lead to more arteries, less plaque. Nature Med. 6, 965–966 (2000). · DOI
  30. Yu, G. et al. Nicastrin modulates presenilin-mediated Notch/Glp-1 signal transduction and βAPP processing. Nature 407, 48–54 (2000). · DOI
  31. Chan, Y -M & Jan, Y. N. Presenilins, processing of β-amyloid precursor protein, and Notch signaling. Neuron 23, 201–204 (1999). · DOI
  32. Brasaemle, D. L., Barber, T., Kimmel, A. R. & Londos, C. Post-translational regulation of perilipin expression. Stabilization by stored intracellular neutral lipids. J. Biol. Chem. 272, 9378–9387 (1997). · DOI
  33. Dixon, J. L. & Ginsberg, H. N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 34, 167–179 (1993). · DOI
  34. Johnson, W. J., Phillips, M. C. & Rothblat, G. H. in Subcellular Biochemistry (ed. Bittman, R.) 235–276 (Plenum, New York, 1997).
  35. Oelkers, P., Behari, A., Cromley, D., Billheimer, J. T. & Sturley, S. L. Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J. Biol. Chem. 273, 26765–26771 (1998). · DOI
  36. Chang, C. C., Huh, H. Y., Cadigan, K. M. & Chang, T. Y. Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 268, 20747–20755 (1993). · DOI
  37. Meiner, V. L. et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl Acad. Sci. USA 93, 14041–14046 (1996). · DOI
  38. Cases, S. et al. ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273, 26755–26764 (1998). · DOI · Paper page
  39. Anderson, R. A. et al. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 273, 26747–26754 (1998). · DOI
  40. Accad, M. et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Invest. 105, 711–719 (2000). · DOI
  41. Krause, B. R. et al. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. J. Lipid Res. 34, 279–294 (1993). · DOI
  42. Sugiyama, Y. et al. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters. Atherosclerosis 113, 71–78 (1995). · DOI
  43. Purchase, T. S. et al. Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agents. Biorg. Med. Chem. 5, 739–747 (1997). · DOI
  44. Murakami, S. et al. ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004. Atherosclerosis 133, 97–104 (1997). · DOI
  45. Harris, W. S. et al. Effects of the ACAT inhibitor CL277,082 on cholesterol metabolism in humans. Clin. Pharmacol. Ther. 48, 189–194 (1990). · DOI
  46. Natory, K., Okazaki, Y., Nakajima, T., Hirohashi, T. & Aono, S. Mechanism of the inhibition of cholesterol absorption by DL-melinamide: inhibition of cholesterol esterification. Jpn J. Pharmacol. 42, 517–523 (1986). · DOI
  47. Blaumueller, C. M., Zagouras, P. & Artavanis-Tsakonas, S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell 90, 281–291 (1997). · DOI
  48. Puglielli, L., Rigotti, A., Greco, A. V., Santos, M. J. & Nervi, F. Sterol carrier protein-2 is involved in cholesterol transfer from the endoplasmic reticulum to the plasma membrane in human fibroblasts. J. Biol. Chem. 270, 18723–18726 (1995). · DOI

Cited by

Sorted by citations

Metadata

Authors
Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A. M., Berezovska, O., Hyman, B. T., Chang, T. Y., Tanzi, R. E., & Kovacs, D. M.
Venue
Nature Cell Biology
Published
2001-09-17
Volume
3
Issue
10
Pages
905-912
ISSN
  • 1465-7392
  • 1476-4679
Cited by
392
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review